December 03, 2024

Roivant Ends Lung Drug After Trial

Roivant discontinues injectable drug namilumab for treating chronic active pulmonary sarcoidosis, citing failure to show treatment benefits in mid-stage trial.

Reuters

November 27, 2024

Key Risk Factors for SARD-ILD Progression

A recent review identified significant risk factors for the progression of systemic autoimmune rheumatic disease-associated interstitial lung disease, emphasizing the importance of early identification and intervention for high-risk patients. The findings provide evidence-based insights for clinicians to guide risk assessment and optimize care.

Conexiant

November 25, 2024

SCOTUS Sidesteps Tobacco Warning Case

The U.S. Supreme Court declined to decide on the legality of graphic health warnings on cigarette packs, sparking ongoing legal battles between tobacco companies and regulatory agencies.

Reuters

July 26, 2024

EHR Use Disparities: Female vs. Male Surgeons

A recent study published in JAMA Network Open reveals gender differences in electronic health record (EHR) usage among surgeons, with female surgeons writing significantly longer progress notes than their male counterparts.

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

June 04, 2024

Urged on by LGBTQ+ Activists, California Cities Weigh Stricter Smoking Rules

The San Francisco Bay Area is spearheading proposals to further restrict tobacco sales and smoking areas, driven by concerns about high smoking rates, especially in the LGBTQ+ community.

KFF Health News

June 25, 2024

Cannabis, Tobacco Use Linked to Severe COVID-19 Outcomes

Cannabis and tobacco use are linked to a higher risk of severe COVID-19 outcomes.

Conexiant

July 24, 2024

New Guideline Provides Recommendations for Managing Central Airway Obstruction

Learn about evidence-based recommendations for managing central airway obstruction in a new clinical guideline from the American College of Chest Physicians.

Conexiant

August 19, 2024

Treprostinil Approval Stalled by FDA

Liquidia’s treprostinil inhaler received tentative approval but faced exclusivity hurdles.

Reuters